MOLECULAR VISION, cilt.19, ss.2571-2578, 2013 (SCI-Expanded)
Purpose: The purpose of this study is to evaluate the effect of complement factor H (CFH) Y402H CC and TT polymorphisms on treatment response to intravitreal ranibizumab injection in patients with wet age-related macular degeneration (AMD).